The Clinical Application of Metabolic Therapy for Cardiovascular Disease

Heart Lung and Circulation

Volumn 16, Issue SUPPL. 3, 2007, Pages

  Hadj, Anthony ^a,b   Pepe, Salvatore ^a,b   Rosenfeldt, Franklin ^a,b  

^a ALFRED HOSPITAL   (Australia)

^b MONASH UNIVERSITY   (Australia)

Author keywords

Alpha lipoic acid; Coenzyme Q10; Exercise; Glucose insulin potassium; Magnesium orotate; Meditation; Metabolic therapy; Omega 3 fatty acids; Stress management

Indexed keywords

ADENOSINE TRIPHOSPHATE; ASCORBIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FREE RADICAL; GLUCOSE; GLUTATHIONE; GLYCOGEN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; MALONALDEHYDE; OMEGA 3 FATTY ACID; OROTATE MAGNESIUM; OROTIC ACID; PLACEBO; POTASSIUM; THIOCTIC ACID; UBIDECARENONE; UBIQUINOL CYTOCHROME C REDUCTASE;

AGING; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; BEHAVIOR CHANGE; BLOOD CLOTTING; BLOOD PRESSURE REGULATION; CARDIOVASCULAR DISEASE; CELL COMPOSITION; CELL ENERGY; CELL MEMBRANE FLUIDITY; CELL METABOLISM; CLINICAL TRIAL; COGNITIVE THERAPY; CONVALESCENCE; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY BYPASS GRAFT; DRUG POTENTIATION; ENERGY YIELD; ENZYME MECHANISM; FEEDBACK SYSTEM; GLYCOLYSIS; HEART FAILURE; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HEART MUSCLE METABOLISM; HEART SURGERY; HEART VENTRICLE ARRHYTHMIA; HUMAN; HYPERTENSION; HYPNOSIS; INTERPERSONAL COMMUNICATION; ISOLATED HEART; KINESIOTHERAPY; MEDITATION; NONHUMAN; OXIDATION REDUCTION STATE; PHYSICAL ACTIVITY; PRIORITY JOURNAL; QUALITY OF LIFE; RELAXATION TRAINING; RELIGION; RISK ASSESSMENT; RUNNING; SOCIAL PSYCHOLOGY; SPORT; STRESS MANAGEMENT; TAI CHI; TREATMENT INDICATION; TREATMENT OUTCOME; WALKING; YOGA;

ADAPTATION, PHYSIOLOGICAL; CARDIOVASCULAR DISEASES; COENZYMES; EXERCISE; GLUCOSE; HEART FAILURE; HUMANS; HYPERTENSION; INSULIN; MEDITATION; OROTIC ACID; PHYSICAL THERAPY MODALITIES; POTASSIUM; THIOCTIC ACID; UBIQUINONE;

EID: 34547736390     PISSN: 14439506     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hlc.2007.04.001     Document Type: Article

References (54)

1. Vericel E., Calzada C., Chapuy P., and Lagarde M. The influence of low intake Omega-3 fatty acids on platelets in elderly people. Atherosclerosis 147 (1999) 187-192
2. Hornstra, G. Omega-3 and Health Benefits. 2001 Roche Vitamins, France.
3. Gerster H. Fish oil (n - 3 long-chain PUFAs) and blood pressure. Nutrition 17 (1993) 15-24
4. James M.J., Gibson R.A., and Cleland L.G. Dietary polyunsaturated fatty acids and inflammatory mediator production. Am J Clin Nutr 71 (2000) 343s-348s
5. Grynberg A., and Demaison L.J. Fatty acid oxidation in the heart. J Cardiovasc Pharmacol 28 Suppl 1 (1996) S11-S17
6. Shah V.Z., Rosenfeldt F.L., Parkin G.W., Ugoni A.M., Habersberger P.G., and Cooper E. Cardiac surgery in the very elderly. Med J Aust 160 (1994) 332-334
7. Lazar H.L., Philippides G., Fitzgerald C., Lancaster D., Shemin R.J., and Apstein C. Glucose-insulin-potassium solutions enhance recovery after urgent coronary bypass surgery. J Thorac Cardiovasc Surg 113 (1997) 354-360 discussion 360-362
8. 10 treatment improves the tolerance of the senescent myocardium to pacing stress in the rat. Cardiovas Res 40 (1998) 165-173
9. 10 improves the tolerance of the senescent myocardium to aerobic and ischaemic stress: studies in rats and in human atrial tissue. BioFactors 9 (1999) 291-299
10. 10 therapy before cardiac surgery improves mitochondrial function and in vitro contractility of myocardial tissue. J Thorac Cardiovasc Surg 129 (2005) 25-32
11. 10 in cardiovascular disease with emphasis on heart failure and myocardial ischaemia. Heart Lung Circ. 7 (1998) 160-168
12. 10 therapy in Class II and III systolic heart failure. Heart Lung Circ 12 (2003) 135-141
13. 10 illuminated by meta-analyses of clinical trials. Mol Aspects Med 18 (1997) S159-S168
14. 10 in physical exercise, hypertension and heart failure. Biofactors 18 (2003) 91-100
15. 10 on systolic function in patients with heart failure. J Card Fail 12 6 (2006) 464-472
16. 10 and essential hypertension. Res Comm Chem Path Pharmacol 11 2 (1975) 273-288
17. 10 on blood pressures and insulin resistance in hypertensive patients with coronary artery disease. J Hum Hypertens 13 3 (1999) 203-208
18. 10 in isolated systolic hypertension. South Med J 94 11 (2001) 1112-1117
19. 10 improves blood pressure and glycaemic control: a controlled trial in subjects with type 2 diabetes. Eur J Clin Nutr 56 11 (2002) 1137-1142
20. 10. Mol Aspects Med 15 (1994) S265-S272
21. 10 in the treatment of hypertension: a meta-analysis of the clinical trials. J Hum Hypertens 21 4 (2007) 297-306
22. Munsch C., Williams J.F., and Rosenfeldt F.L. The impaired tolerance of the recently infarcted rat heart to cardioplegic arrest: the protective effect of orotic acid. J Mol Cell Cardiol 21 (1989) 751-754
23. Newman M.A.J., Chen X.-Z., Rabinov M., Williams J.F., and Rosenfeldt F.L. Sensitivity of the recently infarcted heart to cardioplegia arrest. J Thorac Cardiovasc Surg 97 (1989) 593-604
24. Munsch C., Rosenfeldt F.L., O'Halloran K., Langley L.H., Conyers R.A.J., and Williams J.F. The effect of orotic acid on the impaired tolerance of the recently infarcted rat heart to hypothermic cardioplegia. Eur J Cardiothorac Surg 5 (1991) 82-93
25. Hagen T.M., Moreau R., Suh J.H., and Visio F. Mitochondrial delay in the aging rat heart. Evidence for improvement by dietary Supplementation with acetyl-l-carnitine and/or lipoic acid. Ann of N Y Acad Sci 959 (2002) 491-507
26. Haramaki N., Han D., Handelman G.J., Tritschler H., and Packer L. Cystolic and mitochondrial systems for NADH and NADPH-dependant reduction of alpha-lipoic acid. Free Radic Res Med 22 (1997) 535-542
27. Roy S., and Packer L. Redox regulation of cell functions by alpha-lipoate: biochemical and molecular aspects. Biofactors 7 (1998) 263-267
28. Han D., Handelman G., Marcocci L., Sen C.K., Roy S., Kobuchi H., Tritschler H.J., Flohe L., and Packer L. Lipoic Acid increases de novo synthesis of cellular glutathione by improving cystine utilisation. Biofactors 6 3 (1997) 321-338
29. Suh J.H., Shigeno E.T., Morrow J., Cox B., Rocha A., Frei B., and Hagen T. Oxidative stress in the aging rat heart is reversed by dietary supplementation with (R)-(alpha)-lipoic acid. FASEB J 15 3 (2001) 700-706
30. Panigrahi M., Sadguna Y., Shivakumar B.R., and Kolluri S.V. ALA protects against reperfusion injury following cerebral ischemia in rats. Brain Res. 717 1-2 (1996) 184-188
31. Kingwell B., Waddell T., Medley T., Cameron J., and Dart A. Large artery stiffness predicts ischemic threshold in patients with coronary artery disease. J Am Coll Cardiol 40 4 (2002) 773-779
32. Pepe S., and McLennan P.L. Cardiac membrane fatty acid composition modulates myocardial oxygen consumption and postischemic recovery of contractile function. Circulation 105 (2002) 2303-2308
33. 2+ activation of PDH. Am J Physiol 276 1 Pt 2 (1999) H149-H158
34. Pepe S. Effect of dietary polyunsaturated fatty acids on age-related changes in cardiac mitochondrial membranes. Exp Gerontol 40 (2005) 751-758
35. James M., Gibson R.A., and Cleland L.G. Dietary polyunsaturated fatty acids and inflammatory mediator production. Am J Clin Nutr 71 (2000) 343s-348s
36. Sellmayer A., Witzgall H., Lorenz R.L., and Weber P.C. Effects of dietary fish oil on ventricular premature complexes. Am J Cardiol 76 (1995) 974-977
37. Burr M., Fehily A., Gilbert J., Rogers S., Holliday R., Sweetnam P., Elwood P.C., and Deadman N.M. Effect of changes in fat, fish, and fibre intakes on death and myocardial reinfarction: diet and reinfarction trail (DART). Lancet 2 (1989) 757-761
38. Singh R.B., Niaz M.A., Sharma J.P., Kumar R., Rastogi V., and Moshiri M. Randomised, double-blind, placebo-controlled trial of fish oil and mustard oil in patients with suspected acute myocardial infarction: the Indian experiment of infarct survival, #4. Cardiovasc Drugs Ther 11 (1997) 485-491
39. Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Lancet 1999; 354:447-455.
40. Calo L., Bianconi L., Colivicchi F., Lamberti F., Loricchio M.L., de Ruvo E., Meo A., Pandozi C., Staibano M., and Santini M. N-3 Fatty acids for the prevention of atrial fibrillation after coronary artery bypass surgery: a randomised, controlled trial. J Am Coll Cardiol 45 (2005) 1723-1728
41. Von Schacky C., Angerer P., Kothny W., Theisen K., and Mudra H. The effect of dietary w-3 fatty acids on coronary atherosclerosis. A randomised, double-blind, placebo-controlled trial. Ann Intern Med 130 (1999) 554-562
42. Morris M., Sacks F., and Rosner B. Does fish oil lower blood pressure? A meta-analysis of controlled trials. Circulation 88 (1992) 523-533
43. Clausen J.P. Circulatory adjustments to dynamic exercise and effect of physical training in normal subjects and in patients with coronary heart disease. Prog Cardiovasc Dis 18 (1976) 459-495
44. Scheuer T. Cardiovascular adaptations to physical training. Annu Rev Physiol 45 (1983) 169-189
45. Muller J.E., Abela G., Nesto R., Tofler G.H., and Triggers. acute risk factors and vulnerable plaques: the lexicon of a new frontier. J Am Coll Cardiol 23 (1994) 809-813
46. Williams R.B.J. Psychological factors in coronary heart disease: epidemiologic evidence. Circulation 76 1, pt 2 (1987) I117-I123
47. Blumenthal J.A., and Emery C.F. Rehabilitation of patients following myocardial infarction. J Consult Clin Psychol 56 (1988) 374-381
48. Linden W., Stossel C., and Maurice J. Psychological interventions for patients with coronary artery disease: a meta-analysis. Arch Intern Med 156 (1996) 745-752
49. Hassed C. Meditation in general practice. Australia Family Physician August 25 8 (1996) 1257-1260
50. Good M. Effects of relaxation and music on postoperative pain: a review. J Adv Nurs 24 5 (1996) 905-914
51. Hassed C. Depression: dispirited or spiritually deprived?. MJA 173 (2000) 545-547
52. Matthews D., McCullough M., Larson D., Koenig H., Swyers J., and Milano M. Religious commitment and health status: a review of the research and implications for family medicine. Arch Fam Med 7 2 (1998) 118-124
53. Hassed, C. Mind-body Medicine. Science, Practice and Philosophy. © 2002 Craig Hassed.
54. Hadj A., Esmore D., Rowland M., Pepe S., Schneider L., Lewin J., and Rosenfeldt F. Pre-operative preparation for cardiac surgery utilising a combination of metabolic, physical and mental therapy. Heart Lung Circ J 15 (2006) 172-181